abstract CONTEXT: Studies have suggested that human milk feeding decreases the incidence of retinopathy of prematurity (ROP); however, conflicting results have been reported.
Prematurity is a major contributor to global neonatal mortality. 1 With increases in preterm births globally 2 and major recent advances in management for preterm neonates, the survival of the smallest and sickest neonates has significantly increased. [3] [4] [5] [6] [7] [8] This increase in survival has led to an equivalent increase in long-term morbidities. 7, 9, 10 Recent studies have shown increased incidence of retinopathy of prematurity (ROP) in developed and developing countries, such as the United States, Sweden, China, and Turkey. 8, [11] [12] [13] In extremely preterm infants with a gestational age of 22 to 28 weeks, the incidence of ROP was 59% (96% at 22 weeks and 32% at 28 weeks) according to a large US cohort study. 8 In China, the incidence was .50% in infants with birth weight ,1000 g based on a multicenter epidemiologic study. 12 Globally, ROP has become a leading cause of childhood blindness in recent times. 9 ROP is a multifactorial disease, and risk factors such as low gestational age, oxygen therapy, and oxidative stress have been associated with its development. 10, 14 Human milk is recommended to all preterm infants after birth and has been shown to be effective in preventing necrotizing enterocolitis and lateonset sepsis. 15, 16 Human milk also contains a number of antioxidant components that could be potentially protective against ROP.
There has not been sufficient focus on this subject, and scientific analysis regarding the possible beneficial effect of breast milk on preventing ROP is lacking. The data until now have been scattered and limited to a few clinical studies. 17, 18 Given the ethical implications in conducting a randomized, controlled trial of comparing human milk feeding to formula feeding and the effects on ROP, it is imperative that observational studies provide highquality evidence for comparison.
We systematically reviewed the evidence from observational studies comparing human milk and formula feeding for preventing ROP and present the meta-analysis results.
METHODS
Our study was undertaken to investigate whether human milk is protective against any-stage ROP and severe ROP in comparison with formula feeding. We have followed the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines in reporting our study. 19 
Systematic Search Strategy and Study Selection
Studies published in English were systematically identified though a database search of PubMed, Medline, and EBSCO from their earliest available dates up to February 28, 2015 , using (human milk OR breast milk) AND (retinopathy of prematurity OR necrotizing enterocolitis) as search keywords. We used necrotizing enterocolitis as a search keyword to isolate studies with ROP as secondary outcome, as the topic of "necrotizing enterocolitis and human milk" is widely studied all over the world. In addition, we manually searched relevant journals related to pediatrics and ophthalmology.
Study Selection Criteria
Two authors independently performed study screening of all citations by title and abstract in pairs. The full texts of these studies were then retrieved, and 2 authors independently screened them for inclusion. In both stages, disagreements about inclusion were resolved by discussion or by consulting a third author.
FIGURE 1
Summary of evidence search and study selection. We followed a priori study eligibility criteria for study selection. Any type of observational study (cohort or case-control) was included that compared human milk feeding and formula feeding. We excluded studies that reported only donor human milk feeding.
We determined a priori to report the studies on outcomes that reported ROP at any stage, including severe ROP.
Data Extraction and Quality Assessment
Two authors extracted data from the included studies separately using a structured data extraction sheet. The following details were extracted from each study: authors, year of publication, geographical area, study site, study design, population (gestational age and birth weight), feeding type, ROP diagnosis, relative risk/odds ratio (OR) and 95% confidence interval (CI), and relevant risk factors for ROP besides feeding. If the abstracted data differed between the 2 authors, resolution was conducted through discussion or discussion with a third author.
A critical appraisal was conducted for the observational studies included in the meta-analysis, using the Critical Appraisal Skills Programme (UK) checklist, assessing the validity of the results from each study on a scale of high, medium, and satisfactory: 20 high quality, the study was prospective and scored well on main quality parameters such as study method, result validity, precision of outcomes, and generalizability; medium quality, study method was sound and results were presented with precision; satisfactory quality, the study did not score well or did not contain any information on the main quality parameters such as study method, result validity, precision of outcomes, or generalizability.
Data Synthesis and Statistical Analysis
Data were abstracted from all the studies that met eligibility criteria. All statistical tests in the analysis were 2-tailed, and P values of #.05 were considered significant. Statistical analysis was done using SPSS (version 22, IBM SPSS Statistics, Chicago, IL). Estimates of association between human milk feeding and ROP risk were evaluated by ORs and corresponding 95% CIs. I 2 statistics were applied for the assessment of
FIGURE 2
Forest plots of the summary OR value with corresponding 95% CIs for the correlation between human milk feeding and any-stage ROP.
heterogeneity among studies in the meta-analysis using RevMan (version 5.3.5, Nordic Cochrane Centre, Cochrane Collaboration, London, UK). Evidence summaries were prepared for the included studies by using predetermined output tables.
Role of the Funding Source
This review was conducted as a collaboration of researchers with diverse backgrounds (neonatology, gastroenterology, and public health). No funding was obtained for conducting this study, and all the authors contributed through voluntary efforts.
RESULTS

Selection Results and Included Studies
We identified 1270 citations from the electronic search of the databases from earliest date until February 28, 2015. After duplicate studies were removed, 728 studies were subjected to title and abstract screening. After excluding 418 studies and later including 2 additional studies based on manual searching from relevant journals, 312 studies were subjected to full-text review. Finally, we identified 5 cohort studies for qualitative synthesis and metaanalysis after excluding 307 studies. 17, 18, [21] [22] [23] Fig 1 provides 
2 values of 0%, 27%, 91%, and 0%. In comparing any human milk versus exclusive formula, the outcomes of the individual studies showed poor consistency.
Quality Assessment of Observational Studies
The 5 observational studies included in the meta-analysis were further assessed independently using the Critical Appraisal Skills Program checklist for cohort studies (Table 3) . 20 Based on our assessment, 1 study 17 was rated high, 2 studies 18,21 were rated medium, and 2 studies 22, 23 were rated satisfactory. This implies that the medium-quality studies scored well on all the checklist parameters related to study method and results validity. Whereas the satisfactory-quality studies scored well on parameters related to study method and results validity, specific information pertaining to certain parameters was either unclear or not reported in the studies.
DISCUSSION
ROP is a vasoproliferative disorder of immature retina affecting the vast majority of preterm newborns. The incidence of severe ROP in verypreterm infants weighing ,1250 g could be as high as 37%. 24 Low birth weight and prematurity are strongly associated with increased risk for the disease. 25 ROP is currently the biggest contributor to infant blindness in developed countries, as vision loss occurs secondary to retinal detachment that may occur in the most severe cases. 26 In addition, myopia, strabismus, and amblyopia also occur frequently. 27, 28 The pathogenesis of ROP is multifactorial: besides prematurity and low birth weight, factors such as high-concentration oxygen therapy and suboptimal postnatal nutrition could put infants at significant risk for this devastating eye disease, as established by clinical studies and animal studies. 9, 29 The meta-analysis results of our study indicate that the overall incidence of ROP was reduced among infants fed human milk compared with those fed formula, and exclusive or mainly human milk feeding showed significant benefits in preventing severe ROP.
The underlying physiologic mechanism through which breast milk may protect against the development of ROP may reflect the antioxidant 30 and immuneprotective 31 properties of human milk. In vitro chemical analysis of antioxidant content consistently shows that human milk contains vitamin C, vitamin E, and b-carotene and has greater antioxidant properties than formula. 32, 33 In addition to the antioxidant properties, human milk also contains immunomodulatory substances such as secretory immunoglobulin A, lactoferrin, lysozyme, cytokines, oligosaccharides, antioxidant enzymes, and cellular components. [33] [34] [35] These factors are thought to influence immune defenses of the infant, which may explain the lower risk of necrotizing enterocolitis and sepsis among infants fed human milk. 15,16
FIGURE 3
Forest plots of the summary OR value with corresponding 95% CIs for the correlation between human milk feeding and severe ROP. 21 Furman et al, 2003 22 Heller et al, 2007 18 Maayan-Metzger et al, 2012 23 Manzoni et al, 2013 17 Are the results of the study valid? 21 Furman et al, 2003 22 Heller et al, 2007 18 Maayan-Metzger et al, 2012 23 Manzoni et al, 2013 17 7 What are the results of this study? Explain/ comment Dose-response effect was not observed when categories of human milk were entered into logistic regression results, as duration of feeding was not included; hence results would be precise only to some extent.
Results are not precise, as sample size was not large enough to adequately assess ROP.
Results are precise, as power calculation was conducted for adequate sample size of included infants.
Results are precise to some extent due to the fact that study lacked precise knowledge regarding feeding days and amounts, as well as the use of human milk fortifier consisting of cow milk protein in the HM group. 36 The stage 3 ROP incidences were 19% and 14% in donor milk and formula groups, respectively. The study did not reveal any benefit of donor milk in terms of preventing severe ROP. 36 Another study comparing donor milk and formula feeding also did not demonstrate any benefit in preventing ROP. 37 This contrast may be possibly related to loss of the protective factors in breast milk during processing and storage.
The medical benefits of human milk and the recommendation of human milk as the preferred feeding source for preterm infants limit prospective randomized studies; we therefore selected observational studies for our meta-analysis. This selection could be a limitation to the current metaanalysis. Another limitation is that the definitions of infant feeding were based on retrospective data and could underestimate or overestimate the volume of human milk feeding, and the duration of human milk feeding was not reported in the studies. Of note, in the study of Furman et al, 22 the volume of human milk fed was unknown; to pool the data with the other studies, we included patients fed with $50 mL/kg/day human milk in the "mainly human milk" group. The diagnosis of ROP also varied among studies, further complicating analysis. We resolved this by pooling stage 3 and 4 ROP, surgical ROP, and threshold ROP as a single definition of severe ROP. However, there was lack of long-term prognostic information. Our analysis showed high heterogeneity in some subgroup analyses, so the results in the corresponding analyses should be accepted cautiously and not considered a definitive statement. 21 Furman et al, 2003 22 Heller et al, 2007 18 Maayan-Metzger et al, 2012 23 Manzoni et al, 2013 17 12 8, 12 A randomeffects model for conducting metaanalysis has been suggested as a reasonable way of addressing heterogeneity in pooled studies, and in such cases narratively explaining the reasons for heterogeneity has been proposed. 38 We justify using our meta-analysis approach on the basis of these methodological suggestions.
Notwithstanding these limitations, our meta-analysis has several strengths. Ours is the first systematic analysis of evidence to date regarding the possible benefits of human milk on ROP. We have done multiple database searches, including manually searching relevant journals in pediatrics and ophthalmology, to incorporate maximum published studies concerning our focus. We have followed expected guidelines for meta-analysis of observational studies, which increases the applicability of our results.
We have also reported quality assessment of the included studies in the meta-analysis. Our objective in conducting this exercise was not to assess if the quality of publication should be a criterion for inclusion in the meta-analysis, such that only the high-quality studies are included, but to present how confident can one be in the results presented in the published studies. In doing so, it enables the methodology in these studies to be understood and appraised for the reader.
CONCLUSIONS
In our meta-analysis, longitudinal studies comparing the incidence of ROP in infants who were fed human milk versus formula were selected. Studies involved donor milk were not included. After unifying the definitions of feeding and ROP diagnosis and pooling the data, we found that human milk feeding potentially plays a strong role in protecting very preterm newborns from any-stage ROP and severe ROP. 
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